No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ALVR240517C1000
- 0.05
- 0.000.00%
15min DelayClose Apr 26 13:30 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume34 Open Interest1.00Strike Price0.00Turnover259.13%IV34.68%PremiumMay 17, 2024Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.05Time Value100Contract SizeAmericanOptions Type0.3197Delta1.2355Gamma15.59Leverage Ratio-0.0072Theta0.0000Rho4.99Eff Leverage0.0004Vega
Intraday
- 5D
- 1D
News
Maintaining a Hold: AlloVir's Strategic Uncertainty and Financial Outlook
ALLOVIR SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in AlloVir stock or options between March 22, 2022 and December 21, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson
AlloVir Faces Delisting Risk, Considers Reverse Split to Comply
AlloVir(ALVR.US) Officer Sells US$7,493.92 in Common Stocks
$AlloVir(ALVR.US)$ Officer Hagen Brett R sold 11,150 shares of Common Stocks on Feb 8, 2024 at an average price of $0.6721 for a total value of $7,493.92.Source: Announcement What is statement of chan
Top 4 Health Care Stocks That May Rocket Higher In Q1
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to i
AlloVir To Cut 95% of Workforce After Discontinuing Trials
By Ben Glickman AlloVir will cut about 95% of its current employee base after scrapping three late-stage clinical trials. The cell-therapy developer said in a regulatory filing Thursday that the lay
Comments
AlloVir's reassuring cash runway contrasts with worrying cash burn in relation to its market cap, raising concerns of funding stress and heightening stock uncertainty.
We're Keeping An Eye On AlloVir's (NASDAQ:ALVR) Cash Burn Rate
$AlloVir(ALVR.US$ Hehehe! SUX! But could offer a bottom buy then see if a big Pharmaceutical company offers to buy the rest of their research?![]()
$AlloVir(ALVR.US$ AlloVir Says It Will Discontinue Its Three Phase 3 Posoleucel Studies Following Separate, Pre-planned DSMB Futility Analyses Concluding Studies Were Unlikely To Meet Primary Endpoints
Moomoo 24/7· 1 min ago![]()
Moomoo 24/7· 1 min ago
2
ROOT AAOI RNAZ PIXY BOF TALS PBLA ALVR IVDA LCFY
$Root Inc(ROOT.US$ $Applied Optoelectronics(AAOI.US$ $Transcode Therapeutics(RNAZ.US$ $ShiftPixy(PIXY.US$ $BranchOut Food(BOF.US$ $Talaris Therapeutics(TALS.US$ $Panbela Therapeutics(PBLA.US$ $AlloVir(ALVR.US$ $Iveda Solutions(IVDA.US$ $Locafy(LCFY.US$
$Root Inc(ROOT.US$ $Applied Optoelectronics(AAOI.US$ $Transcode Therapeutics(RNAZ.US$ $ShiftPixy(PIXY.US$ $BranchOut Food(BOF.US$ $Talaris Therapeutics(TALS.US$ $Panbela Therapeutics(PBLA.US$ $AlloVir(ALVR.US$ $Iveda Solutions(IVDA.US$ $Locafy(LCFY.US$
2
1
A lot a news…..but…..
$Applied Optoelectronics(AAOI.US$ $Ault Disruptive Technologies Corporation(ADRT.US$ $AlloVir(ALVR.US$ $BranchOut Food(BOF.US$ $Chemomab Therapeutics(CMMB.US$ $Cognizant(CTSH.US$ $Greenpro Capital(GRNQ.US$ $IDEX Corp(IEX.US$ $Eightco Holdings(OCTO.US$ $ShiftPixy(PIXY.US$ $Root Inc(ROOT.US$ $PTC Therapeutics(PTCT.US$ $Summit Therapeutics(SMMT.US$ $ZoomInfo(ZI.US$
4
Read more